Authors

Peter Pitts

Peter Pitts is president and co-founder of the Center for Medicine in the Public Interest. He also serves as a visiting professor at the University of Paris School of Medicine. Pitts is a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration where he served as senior communications and policy adviser to the Commissioner. He supervised FDA's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management. He served on the agency’s obesity working group and counterfeit drug taskforce. He is a member of the Council for International Organizations of Medical Sciences (CIOMS) Expert Working Group to help advance patient involvement in the development and safe use of medicines.

Dracey Poore

Dracey Poore is the director of biosimilars at Cardinal Health. She is also a member of The Center for Biosimilars

Juliana M. Reed

Kristi Rosa

Cameron Santoro

Cameron Santoro is an associate editor for The Center for Biosimilars

Marion Schauf, Dipl-Kff

St John Skilton, PhD

As vice president of product strategy and marketing, St John Skilton manages the new product development at Protein Metrics Inc. With deep domain experience in MS and related analytical tools the biopharmaceutical industry, Skilton has been at the forefront of development for many years.

Amber Skrtic, PharmD

Amber Skrtic, PharmD, CSP, AAHIVP, is Vice President of Trade Relations for CPS Solutions.

Pearl Steinzor

Susan Trieu, PharmD

Susan Trieu, PharmD, is Senior Vice President of Specialty Clinical Strategy and Trend for CPS Solutions